Literature DB >> 3874642

Use of an emulsion of ICI 35868 (propofol) for the induction and maintenance of anaesthesia.

N H Kay, J Uppington, J W Sear, M C Allen.   

Abstract

2,6-Diisopropyl phenol in a fat emulsion formulation (propofol) has been used to supplement 67% nitrous oxide in oxygen anaesthesia in 20 patients premedicated with morphine 0.15 mg kg-1 and atropine 0.6 mg, and undergoing body surface surgery. Following an induction dose of propofol 2.5 mg kg-1, the mean maintenance dose was 73.4 micrograms kg-1 min-1. When compared with 10 patients receiving Althesin to supplement nitrous oxide in oxygen in a similar manner, recovery was considerably faster following propofol. The only major side-effect associated with the use of propofol was pain on injection in nine out of 20 patients. When the patients receiving propofol were compared with a second control group (n = 11) in whom anaesthesia was induced with thiopentone 4 mg kg-1 and maintained with 1% halothane and nitrous oxide in oxygen, the former group showed a significant (P less than 0.01) decrease in the plasma cortisol concentration 30 min after the induction of anaesthesia. However, by 3 h after induction, the cortisol concentration in both groups was not significantly different from the baseline (preinduction) value. The mechanism of this decrease is not known. Investigation of the influence of the fat emulsion on blood coagulation and fibrinolysis revealed no differences when compared with patients receiving Althesin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874642     DOI: 10.1093/bja/57.8.736

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

2.  Anesthetic properties of a propofol microemulsion in dogs.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Dinesh O Shah; Brian Klatt; George P Thomas; Frank A Kero; Matthew M Booth; Donn M Dennis
Journal:  Anesth Analg       Date:  2006-10       Impact factor: 5.108

3.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

4.  Thromboelastographic and pharmacokinetic profiles of micro- and macro-emulsions of propofol in swine.

Authors:  Timothy E Morey; Jerome H Modell; Jorge E Garcia; Michael Bewernitz; Hartmut Derendorf; Manoj Varshney; Nikolaus Gravenstein; Dinesh O Shah; Donn M Dennis
Journal:  Biopharm Drug Dispos       Date:  2010-07       Impact factor: 1.627

Review 5.  New iv induction anaesthetics.

Authors:  D H Morison
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

6.  Use of an anesthesia information management system (AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anesthesia.

Authors:  M Benson; A Junger; C Fuchs; L Quinzio; S Böttger; G Hempelmann
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 7.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 8.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  A comparison of propofol and thiopentone as induction agents in outpatient surgery.

Authors:  G Edelist
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

10.  A comparison of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft surgery.

Authors:  R I Hall; J T Murphy; E A Moffitt; R Landymore; P T Pollak; L Poole
Journal:  Can J Anaesth       Date:  1991-11       Impact factor: 5.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.